Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Francesco Bassi

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Pathology, Research and Practice|March 19, 2018
Corrigendum to "Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy)" [Pathol. Res. Pract. 213 (2017) 1078-1081]Francesco Pierconti, Patrizia Straccia, Sacco Emilio, et al.
Urologic Oncology|September 25, 2010
Advanced bladder cancer: new agents and new approaches. A reviewAndrea Volpe, Marco Racioppi, Daniele D'Agostino, et al.
Pathology, Research and Practice|August 28, 2017
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy)Francesco Pierconti, Patrizia Straccia, Sacco Emilio, et al.
Journal of Clinical Pathology|June 13, 2020
Methylation study of the Paris system for reporting urinary (TPS) categoriesFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Urologic Oncology|August 11, 2020
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?Francesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, et al.
Urologic Oncology|December 14, 2021
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinomaFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Human Pathology|September 28, 2021
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samplesFrancesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, et al.
Virchows Archiv : an International Journal of Pathology|February 9, 2020
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG respondersFrancesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2020
Correction to: PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG respondersFrancesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, et al.
Clinical Nuclear Medicine|April 23, 2013
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated positionGirolamo Tartaglione, Alessandro D'Addessi, Chiara De Waure, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Pathology, Research and Practice|March 19, 2018
Corrigendum to "Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy)" [Pathol. Res. Pract. 213 (2017) 1078-1081]Francesco Pierconti, Patrizia Straccia, Sacco Emilio, et al.
Urologic Oncology|September 25, 2010
Advanced bladder cancer: new agents and new approaches. A reviewAndrea Volpe, Marco Racioppi, Daniele D'Agostino, et al.
Pathology, Research and Practice|August 28, 2017
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy)Francesco Pierconti, Patrizia Straccia, Sacco Emilio, et al.
Journal of Clinical Pathology|June 13, 2020
Methylation study of the Paris system for reporting urinary (TPS) categoriesFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Urologic Oncology|August 11, 2020
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?Francesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, et al.
Urologic Oncology|December 14, 2021
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinomaFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Human Pathology|September 28, 2021
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samplesFrancesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, et al.
Virchows Archiv : an International Journal of Pathology|February 9, 2020
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG respondersFrancesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2020
Correction to: PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG respondersFrancesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, et al.
Clinical Nuclear Medicine|April 23, 2013
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated positionGirolamo Tartaglione, Alessandro D'Addessi, Chiara De Waure, et al.
Pageof 7